Sunday, June 12, 2011

Hematological Malignancies Program-NCBS

Hematological Malignancies Program: Practical and Theory CourseOctober 24 to November 7, 2011
Venue : National Centre for Biological sciences, Bangalore, St. Johns Medical College, Bangalore
 
Scientific Organizers :
  • Sudhir Krishna, NCBS 
  • Cecil Ross, St. Johns Medical College
  • Seema Nanda, CAM-TIFR 
  • Francoise Pflummio and P.H. Romeo, France
Hematological research in the last few decades both internationally and in India has prospered in a context where there is a high quality critical mass of both research scientists and clinicians who have both familiarity with domains beyond their primary expertise and have easy access to each other and their respective resources.
The primary purpose of the course is to familiarize research scientists (students/post doctoral fellows/principal investigators) with the
  • the techniques that are driving research questions in contemporary hematology with a bias towards hematological malignancies
  • to familiarize research scientists whose primary domain knowledge tends to be in biochemistry, biophysics, genetics, molecular biology etc with critical medical subjects such as pathology (inclusive of lab based hematology) and clinical hematology
The secondary purpose of the course is
  • To offer an opportunity for interested clinicians at any stage of their career to get a hands on exposure to techniques that have become essential in the practice of modern hematology
The overall structure of the course is to have a combination of :
  • Wet lab experiments
  • Theory classes and tutorials
  • Research seminars
  • Journal club presentations
  • Clinical case studies in hematology
  • Large scale data handling and bio-informatics
  • Clinically oriented classes as part of the European Hematology Highlights course
  • Experimental protocols that will be covered in the course :
The experiments will broadly come under two categories i) Morphological analysis of leukemias and leukemic stem cells and ii) genetic analysis of leukemic cells
(The number and type of experiments that each course participant will undertake will be decided on an individual basis with the expectation that some of the participants will also serve as teaching assistants)
# Morphological Analysis of leukemias and leukemic stem cells
  1. Pathology of luekemias: diagnostic features, characterization of blast cells etc.
  2. Flow sorting of leukemic cells and putative leukemic stem cells with specific markers.
  3. Bone marrow cultures
  4. Cellular growth and proliferation assays inclusive of dye labeling studies, explorating assays using inhibitors that target epigenetic processes etc.
# Genetic analysis of leukemic cells
  1. Fish and chromosomal analysis
  2. Gene expression analysis: Quantitative RT-PCR of specific genes in the hematopoietic lineage/leukemic cells
  3. Handling large scale genomic analysis information and bio-informatics
Lecture themes :1.Introduction to bone marrow and pathology of leukemias
2.Chronic Myeloid leukemia- diagnosis, prognosis, molecular biological tools in diagnosis
and treatment protocols
3.Chronic Myeloid leukemia- the evolution of BCR-ABL inhibitors, therapeutic resistance and the structural biology of kinases 
4.Hematopoietic development stem cells, discovery, isolation, key concepts
5.Transcription factors, gene expression in hematopoietic lineage development
6.Leukemic stem cells- discovery, characterization with a focus on AML
7.ALLs, the biology and successes in peadiatric disease
8.Minimal Residual disease- review of the techniques and comment on the value in different clinical settings
9.Status of transplants in hematological and hematological malignancies- 
10.Epigenetics: both large scale and specific genes in leukemias
11.Genome sequencing in leukemias, mutations identified, population distribution, 
12.MicroRNAs in leukemias; review and clinical possibilities
13.Targeting signaling pathways in leukemias, JAK-STAT etc.
Tutorials in the form of student presentation :
1.What are the challenges in identification of  leukemic stem cells apart from AML 
2.What are the likely diagnostic, therapeutic and prognostic implications of research in leukemic stem cells
3.Minimal Residual disease: what are the potential technical improvements ?
4.What are the bottle necks in transplants and potential research questions ?
Students for the course : We are aiming for around 20 inclusive of clinical stream. Open to any biology researchers, with a bias to students already involved in cancer (hematological malignancies) biology and in the labs involved in setting up/aiding the collaborative NCBS-St. John’s programme. This bias essentially stems from the need to build a local critical mass as the first step in parallel to developing both interactions/training on a broad scale. A critical appraisal of the present course would allow for improvement in subsequent years.

No comments:

Post a Comment